• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WANG Yunshan, WANG Jie, WANG Xiaonan, JIANG Cuihua, ZHENG Xian, ZHANG Jian, YIN Zhiqi. Therapeutic effects of gypenosides on hypercholesterolemia and it protective effect on liver injury[J]. Journal of China Pharmaceutical University, 2021, 52(1): 84-91. DOI: 10.11665/j.issn.1000-5048.20210112
Citation: WANG Yunshan, WANG Jie, WANG Xiaonan, JIANG Cuihua, ZHENG Xian, ZHANG Jian, YIN Zhiqi. Therapeutic effects of gypenosides on hypercholesterolemia and it protective effect on liver injury[J]. Journal of China Pharmaceutical University, 2021, 52(1): 84-91. DOI: 10.11665/j.issn.1000-5048.20210112
shu

Therapeutic effects of gypenosides on hypercholesterolemia and it protective effect on liver injury

  • 1.

    Department of TCMs Pharmaceuticals, School of TCM＆State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009

  • 2.

    Laboratory of Translational Medicine, Jiangsu Provincial Academy of Traditional Chinese Medicine, Nanjing 210028, China

Funds: This study was supported by the QingLan Project of Colleges and Universities of Jiangsu Province, the College Students′ Innovation and Entrepreneyrship Projects (No. 202010316044S) and the Postgraduate Research & Practice Innovation Program of Jiangsu Province (No.KYCX20_0676).
More Information
  • Received Date: October 29, 2020
  • Revised Date: December 19, 2020
    Graphical Abstract
    • Abstract
  • In order to explore the therapeutic effects and preliminary mechanism of gypenosides (GP) on hypercholesterolemia, as well as the protective effect on liver injury induced by high-dose simvastatin and high cholesterol diet (HCD), the hypercholesterolemia model of golden hamster was established by high cholesterol diet. The experimental animals were divided into blank group, model group, GP low and high dose groups (60 mg/kg, 120 mg/kg), simvastatin group (10 mg/kg), and GP high dose combined with simvastatin group (120 mg/kg + 10 mg/kg).The efficacy was investigated through dynamic monitoring serum cholesterol and liver function related indexes after drug treatment of 14 and 23 days. The results showed that GP could significantly reduce the levels of serum low density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triglyceride (TG), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP), increase the level of serum high density lipoprotein cholesterol (HDL-C), and reduce the secretion of PCSK9. It is suggested that GP has a good therapeutic effect on HCD diet-induced hypercholesterolemia hamsters, which may be related to its inhibition of PCSK9 secretion. In addition, GP can significantly ameliorate liver damage caused by HCD diet and high-dose simvastatin. These findings provide a scientific basis and useful reference for the combination of GP and statins to reduce toxicity and increase efficacy.
    • FullText(HTML)
    • References (17)
  • [1]
    . Clin Ther， 2016， 38（7）： 1696-1709.
    [2]
    Bj?rnsson E， Jacobsen EI， Kalaitzakis E. Hepatotoxicity associated with statins： reports of idiosyncratic liver injury post-marketing［J］. J Hepatol， 2012， 56（2）： 374-380.
    [3]
    Hazen SL. New lipid and lipoprotein targets for the treatment of cardiometabolic diseases［J］. J Lipid Res， 2012， 53（9）： 1719-1721.
    [4]
    Chen SK. A classificatory system and geographical distribution of the genus Gynostemma BL［J］. Acta Phytotaxon Sin（植物分类学报）， 1995，33（4）： 403-410.
    [5]
    Jeenduang N， Sangkaew B， Chantaracha P， et al. APOE and CETP TaqIB polymorphisms influence metabolic responses to Hibiscus sabdariffa L. and Gynostemma pentaphyllum Makino tea consumption in hypercholesterolemic subjects［J］. Asia Pac J Clin Nutr， 2017， 26（2）： 368-378.
    [6]
    Zhang YD， Jiang XY， Cao LJ， et al. Gypenoside granules improved lipid metabolism in C57BL/6J mice with hyperlipidemia［J］. J China Pharm Univ（中国药科大学学报）， 2019， 50（6）： 713-720.
    [7]
    Wu LS， Qian MZ. Effects of gypenosides on PCSK9 gene expression and blood lipids lowered by simvastatin［J］. Chin J Pathol（中华病理学杂志）， 2017， 33（1）： 79-85.
    [8]
    Shen TT， Hua EB， Ma N， et al. Effects of phlorizin on hepatic cholesterol metabolism genes expression in hamsters fed high fat and cholesterol diet［J］. Acta Nutr Sin（营养学报）， 2014， 36（2）： 159-163.
    [9]
    Dong B， Wu MH， Li H， et al. Strong induction of PCSK9 gene expression through HNF1α and SREBP2： mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters［J］. J Lipid Res， 2010， 51（6）： 1486-1495.
    [10]
    Li HS， Ying H， Hu AR， et al. Therapeutic effect of gypenosides on nonalcoholic steatohepatitis via regulating hepatic lipogenesis and fatty acid oxidation［J］. Biol Pharm Bull， 2017， 40（5）： 650-657.
    [11]
    Chen JX. Study on liver-protective effect of total saponins of Gynostemma pentaphyllum［J］. China Pharm（中国药业）， 2007， 16（13）： 7-8.
    [12]
    Armitage J， Bowman L， Collins R， et al. Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20， 536 high-risk people［J］. BMC Clin Pharmacol， 2009， 31（9）： 6.
    [13]
    Kanasaki A， Jiang Z， Mizokami T， et al. Dietary D-allulose alters cholesterol metabolism in Golden Syrian hamsters partly by reducing serum PCSK9 levels［J］. J Funct Foods， 2019， 60： 103429-103429.
    [14]
    Kang ZY， Chu XX， Yang RM， et al. Study on the biomarkers of cholesterol metabolic disorder in hyperlipemia model of golden hamster［J］. Chin Pharmacol Bull（药学通报）， 2014， 30（6）： 880-883.
    [15]
    Madsen CS， Janovitz E， Zhang R， et al. The guinea pig as a preclinical model for demonstrating the efficacy and safety of statins［J］. J Pharmacol Exp Ther， 2008， 324（2）： 576-586.
    [16]
    Ito BR， Zhang BH， Cable EE， et al. Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits， dogs and monkeys［J］. Br J Pharmacol， 2009， 156（3）： 454-465.
    [17]
    Pel P， Chae HS， Nhoek P， et al. Chemical constituents with proprotein convertase subtilisin/kexin type 9 mRNA expression inhibitory activity from dried immature Morus alba fruits［J］. J Agric Food Chem， 2017， 65（26）： 5316-5321.
    • Related Articles

  • Related Articles

    [1]YE Zhenning, WU Zhenghong, ZHANG Huaqing. Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system[J]. Journal of China Pharmaceutical University, 2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202
    [2]YONG Qin, YUE Hanxun, SHI Min, HUANG Shiqin, ZHAO Xuan, YU Xian. Construction and in vitro evaluation of pH-responsive and tumor-targeted PTEN/PLGA-(HE)10-MAP nanoparticles[J]. Journal of China Pharmaceutical University, 2021, 52(3): 301-310. DOI: 10.11665/j.issn.1000-5048.20210306
    [3]FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
    [4]SONG Ke, PAN Hao, HAN Jiayi, CHEN Lijiang. Nano drug delivery system based strategies to target tumor microenvironment[J]. Journal of China Pharmaceutical University, 2018, 49(4): 392-400. DOI: 10.11665/j.issn.1000-5048.20180402
    [5]FAN Qianqian, XING Lei, QIAO Jianbin, ZHANG Chenglu, JIANG Hulin. Advances in drug delivery systems for the treatment of liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(3): 263-271. DOI: 10.11665/j.issn.1000-5048.20180302
    [6]SUN Jingfang, GUO Chunjing, ZHANG Yunduan, SONG Xiaoyan, LYU Jiantao, YIN Jungang, CHEN Daquan. Preparation and characterization of multi-functional targeting nano-carrier based on pH-redox tumor microenvironment[J]. Journal of China Pharmaceutical University, 2017, 48(3): 305-310. DOI: 10.11665/j.issn.1000-5048.20170309
    [7]HE Wei, QI Haixia, DONG Lei, ZHANG Junfeng. Research advances in drug delivery system targeting immune system[J]. Journal of China Pharmaceutical University, 2015, 46(5): 513-520. DOI: 10.11665/j.issn.1000-5048.20150501
    [8]ZHANG Zhiqing, WANG Fang, ZHOU Ting, ZHANG Guodong, WANG Xiufeng, LI Yunze. A DNA polyaptamer system as a targeted antitumor drug delivery[J]. Journal of China Pharmaceutical University, 2015, 46(4). DOI: 10.11665/j.issn.1000-5048.20150408
    [9]SU Zhigui, MO Ran, ZHANG Can. Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor[J]. Journal of China Pharmaceutical University, 2015, 46(1): 28-39. DOI: 10.11665/j.issn.1000-5048.20150103
    [10]KE Xue. Advances in targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(1): 9-15.

Catalog

    Get Citation
    PDF
    XML
    Article views (316) PDF downloads (669) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：327247

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return